Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Alzheimer's Research & Therapy 7 (2015):S. 40-48.

Keyword: -
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Event: Veröffentlichung

(where): Erlangen

(who): Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

(when): 2015

Contributor: Kvartsberg, Hlin
Portelius, Erik
Andréasson, Ulf
Brinkmalm, Gunnar
Hellwig, Konstantin
Lelental, Natalia
Kornhuber, Johannes
Hansson, Oskar
Minthon, Lennart
Spitzer, Philipp
Maler, Juan M.
Zetterberg, Henrik
Blennow, Kaj
Lewczuk, Piotr

URN: urn:nbn:de:bvb:29-opus4-66306

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kvartsberg, Hlin
Portelius, Erik
Andréasson, Ulf
Brinkmalm, Gunnar
Hellwig, Konstantin
Lelental, Natalia
Kornhuber, Johannes
Hansson, Oskar
Minthon, Lennart
Spitzer, Philipp
Maler, Juan M.
Zetterberg, Henrik
Blennow, Kaj
Lewczuk, Piotr
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

2015

Other Objects (12)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Hochschulschrift

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Hochschulschrift

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Hochschulschrift

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls

Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Blood‐based biomarkers for Alzheimer's disease

[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case

Diversitätsintelligenz

Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

Related objects

Reset password